EGFR and non-small cell lung carcinoma: Prior studies looking at patients with EGFR-mutated NSCLC undergoing treatment with TKIs have used variable NLR cutoff values, frequently chosen to reflect the top quartile of the study population or to maximize the receiver operating characteristic (ROC) curve.